Session Type
Meeting
Search Results
Abstract Number: 0142
SHM Converge 2025
Background: Self-directed discharge, also known as Against Medical Advice (AMA) discharges, comprise 1–2% of hospital discharges (1). The AMA process poses safety risks to patients and emotional strain on providers, potentially leading to implicit biases in documentation (2). While stigmatizing language in medical records has gained attention (3), its prevalence in AMA documentation remains underexplored. [...]
Abstract Number: 0143
SHM Converge 2025
Background: The decision to reinitiate anticoagulation after a trauma admission is complex. There have been limited studies on post-discharge outcomes of patients who are restarted on therapeutic anticoagulation after traumatic injury versus those who have had anticoagulation discontinued. Methods: All consecutive patients on anticoagulants who were admitted to Saint Marys Hospital in Rochester, Minnesota for [...]
Abstract Number: 0144
SHM Converge 2025
Background: In 2022, healthcare spending in the US accounted for 17.3% of its GDP(1), yet the US ranked near the bottom among high-income nations for key health outcomes. It is unclear if a similar relationship exists between spending and health outcomes across US Hospitals. Centers for Medicare and Medicaid Services (CMS) reports a standardized risk-adjusted [...]
Abstract Number: 0145
SHM Converge 2025
Background: Stroke is a leading cause of long-term disability in the U.S., with many being attributable to lifestyle-related risk factors. Obesity and diabetes, in particular, have been shown to significantly increase the risk of having a stroke. However, the connection between these conditions and the severity of stroke is not as well understood. Some research [...]
Abstract Number: 0146
SHM Converge 2025
Background: Before any gastrointestinal (GI) procedures, it is recommended that patients have no intake of clear liquids (2-4 hours) and solid food (6 hours) prior to induction of sedation to minimize preoperative risks such as regurgitation, pulmonary aspiration, and other risks associated with sedation. These time frames were determined by previous randomized control trials which [...]
Abstract Number: 0148
SHM Converge 2025
Background: Most primates, including humans, belonging to the suborder Haplorrhine lack the innate ability to synthesize ascorbic acid (Vitamin C) and hence exclusively depend on dietary intake (generally plant-based diets) to prevent deficiency. Modern humans’ trend of consuming ultra-processed foods that lack crucial micronutrients places us at risk for developing micronutrient deficiencies. Currently, there is [...]
Abstract Number: 0149
SHM Converge 2025
Background: Acute Decompensated Heart Failure (ADHF) is responsible for over a million hospitalizations per year in the US and Europe. The American Heart Association Guidelines for treatment of patients hospitalized with ADHF recommend intravenous (IV) diuresis with loop diuretics to reduce fluid overload until vascular congestion is relieved. However, the optimal dosing strategy for IV [...]
Abstract Number: 0150
SHM Converge 2025
Background: In Texas, the five-year survival rate for lung cancer is significantly lower compared to the national average with noted disparities in early diagnosis and treatment. The aim of this study is to assess sex, ethnic and racial differences in end-of-life healthcare utilization, advance care planning (ACP) and associated outcomes such as hospice use among [...]
Abstract Number: 0152
SHM Converge 2025
Background: Hypertension and diabetes are common comorbidities frequently managed by primary care physicians. Poorly controlled cases of these conditions can lead to increased healthcare resource utilization. We conducted a prospective pilot study involving high-risk patients with hypertension and diabetes to evaluate whether a multidisciplinary team approach could lead to improved clinical outcomes and reduced healthcare [...]
Abstract Number: 0153
SHM Converge 2025
Background: In 2019, the US Food & Drug Administration issued a warning regarding safety of gabapentin use in patients with respiratory conditions, including chronic obstructive pulmonary disease (COPD). Gabapentin is widely prescribed, often for off-label indications, however limited data exist regarding safety and outcomes among patients with COPD. Methods: We analyzed data from 29 US [...]